(S1 (S (S (NP (NP (NP (JJ Homeostatic) (NN control)) (PP (IN of) (NP (NN uridine)))) (CC and) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN uridine) (NN phosphorylase))))) (: :) (NP (DT a) (ADJP (ADJP (JJ biological)) (CC and) (ADJP (JJ clinical))) (NN update))) (. .)))
(S1 (S (S (NP (NP (NN Uridine)) (, ,) (NP (NP (DT a) (NN pyrimidine) (NN nucleoside)) (ADJP (JJ essential) (PP (IN for) (NP (NP (DT the) (NN synthesis)) (PP (IN of) (NP (NP (NN RNA)) (CC and) (NP (NN bio-membranes)))))))) (, ,)) (VP (VBZ is) (NP (NP (NP (DT a) (JJ crucial) (NN element)) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (JJ normal) (JJ physiological) (NNS processes)))))) (CONJP (RB as) (RB well) (IN as)) (NP (JJ pathological) (NNS states))))) (. .)))
(S1 (S (S (NP (NP (DT The) (JJ biological) (NNS effects)) (PP (IN of) (NP (NN uridine)))) (VP (VBP have) (VP (VBN been) (VP (VBN associated) (PP (PP (IN with) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (DT the) (JJ cardio-circulatory) (NN system))))) (, ,) (PP (IN at) (NP (DT the) (NN reproduction) (NN level))) (, ,) (PP (IN with) (NP (ADJP (CC both) (ADJP (JJ peripheral)) (CC and) (ADJP (JJ central) (JJ nervous))) (NN system) (NN modulation))) (CC and) (PP (IN with) (NP (NP (DT the) (NN functionality)) (PP (IN of) (NP (DT the) (JJ respiratory) (NN system)))))))))) (. .)))
(S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (NN uridine)) (VP (VBZ plays) (NP (NP (DT a) (NN role)) (PP (IN at) (NP (DT the) (JJ clinical) (NN level)))) (PP (IN in) (S (VP (VBG modulating) (NP (NP (DT the) (JJ cytotoxic) (NNS effects)) (PP (IN of) (NP (NP (NNS fluoropyrimidines)) (PP (IN in) (NP (ADJP (CC both) (ADJP (JJ normal)) (CC and) (ADJP (JJ neoplastic))) (NNS tissues))))))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NN concentration)) (PP (IN of) (NP (NN uridine))) (PP (IN in) (NP (NP (NN plasma)) (CC and) (NP (NNS tissues))))) (VP (VBZ is) (ADVP (RB tightly)) (VP (VBN regulated) (PP (PP (IN by) (NP (JJ cellular) (NN transport) (NNS mechanisms))) (CC and) (PP (IN by) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (NP (NP (NN uridine) (NN phosphorylase)) (PRN (-LRB- -LRB-) (NP (NN UPase)) (-RRB- -RRB-))) (, ,) (ADJP (JJ responsible) (PP (IN for) (NP (NP (DT the) (JJ reversible) (NN phosphorolysis)) (PP (IN of) (NP (NN uridine))) (PP (TO to) (NP (NN uracil)))))))))))))) (. .)))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (ADVP (RB recently)) (VP (VBN completed) (NP (NP (JJ several) (NNS studies)) (VP (VBN designed) (S (VP (TO to) (VP (VP (VB define) (NP (NP (DT the) (NNS mechanisms)) (VP (VBG regulating) (NP (NN UPase) (NN expression))))) (CC and) (ADVP (RB better)) (VP (VB characterize) (NP (NP (DT the) (JJ multiple) (JJ biological) (NNS effects)) (PP (IN of) (NP (NN uridine))))))))))))) (. .)))
(S1 (S (S (NP (NP (JJ Immunohistochemical) (NN analysis)) (CC and) (NP (NN co-purification) (NNS studies))) (VP (VBP have) (VP (VBN revealed) (NP (NP (DT the) (NN association)) (PP (IN of) (NP (NN UPase))) (PP (IN with) (NP (NP (DT the) (NN cytoskeleton)) (CC and) (NP (DT the) (JJ cellular) (NN membrane)))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NN characterization)) (PP (IN of) (NP (NP (DT the) (NN promoter) (NN region)) (PP (IN of) (NP (NN UPase)))))) (VP (VBZ has) (VP (VBN indicated) (NP (NP (DT a) (JJ direct) (NN regulation)) (PP (IN of) (NP (PRP$ its) (NN expression))) (PP (IN by) (NP (DT the) (NN tumor) (NN suppressor) (NN gene) (NN p53))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NN evaluation)) (PP (IN of) (NP (JJ human) (JJ surgical) (NNS specimens)))) (VP (VBZ has) (VP (VBN shown) (NP (NP (JJ elevated) (NN UPase) (NN activity)) (PP (IN in) (NP (NN tumor) (NN tissue)))) (PP (VBN compared) (PP (TO to) (NP (JJ paired) (JJ normal) (NN tissue))))))) (. .)))
